Jeff Carlson
@themarketswork
Another fishy thing: The first place the new mRNA technology was employed was in the development of new mRNA vaccines that were intended for use against the 2018 outbreaks of Ebola in West Africa.
But, as John Hopkins noted, "since that virus is only found in a limited number of African countries, it had no commercial development in the U.S.”
So, from the viewpoint of the pharma companies, they had this newly improved mRNA technology that they theoretically could use to make much cheaper “vaccine alternatives” but they had no large, commercially viable markets in which to sell this new technology.
And of course, there were no long-term safety studies of the mRNA vaccines. In other words, if things continued as they had pre-Covid, it would have likely been years, perhaps even decades, before mRNA vaccines would have been accepted or used in the Western world. But then Covid hit and everything changed.
Side Note: Many have speculated the Zaire Ebola outbreak may have come the Kenema Lab in Sierra Leone. The outbreak happened in the near vicinity of the lab - more than 3,000km away from Zaire Ebola's natural source in the Congo.
Those running the lab: Proximal Origin authors Kristian Andersen & Robert Garry. Small world, isn't it...
12:48 PM · Mar 15, 2024
Thomas Massie
@RepThomasMassie
A fishy thing:
The mRNA vaccine was trialed within 2 months of COVID appearing in the U.S., but it took a year to come up with a vaccine to target a slight variant.
Inference: The original variant was built by humans to develop the vaccine; that’s how we had its blueprint.
11:11 AM · Mar 15, 2024